Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis

IL-1β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and membrane-bound receptors, respectively. The effectiveness of the cytokine depends not only on the percentage of receptor-positive cells in an...

Full description

Saved in:
Bibliographic Details
Published in:Mediators of Inflammation Vol. 2015; no. 2015; pp. 1006 - 1014-493
Main Authors: Sennikov, Sergey V., Karaulov, Aleksander V., Sizikov, Aleksey E., Chumasova, Oksana A., Shkaruba, Nadezhda S., Anatolievna, Lopatnikova Julia, Alshevskaya, Alina A., Kozlov, Vladimir A.
Format: Journal Article
Language:English
Published: Cairo, Egypt Hindawi Limiteds 01-01-2015
Hindawi Publishing Corporation
John Wiley & Sons, Inc
Hindawi Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract IL-1β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and membrane-bound receptors, respectively. The effectiveness of the cytokine depends not only on the percentage of receptor-positive cells in an immunocompetent subset but also on the density of receptor expression. The objective of this study was to investigate the expression of IL-1β membrane-bound receptors (IL-1R1 and IL-1R2) in terms of the percentage of receptor-positive cells and the number of receptors per cell in different subsets of immune cells in RA patients before and after a course of basic (excluding anticytokine) therapy and in healthy individuals. The resulting data indicate differences in the expression of IL-1β receptors among T cells, B cells, and monocytes in healthy volunteers and in rheumatoid arthritis patients. The importance of determining both the relative percentage of cells expressing receptors to immunomodulatory cytokines and the number of membrane-bound receptors per cell is highlighted by evidence of unidirectional or multidirectional changing of these parameters according to cell subset and health status.
AbstractList IL‐1 β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and membrane‐bound receptors, respectively. The effectiveness of the cytokine depends not only on the percentage of receptor‐positive cells in an immunocompetent subset but also on the density of receptor expression. The objective of this study was to investigate the expression of IL‐1 β membrane‐bound receptors (IL‐1R1 and IL‐1R2) in terms of the percentage of receptor‐positive cells and the number of receptors per cell in different subsets of immune cells in RA patients before and after a course of basic (excluding anticytokine) therapy and in healthy individuals. The resulting data indicate differences in the expression of IL‐1 β receptors among T cells, B cells, and monocytes in healthy volunteers and in rheumatoid arthritis patients. The importance of determining both the relative percentage of cells expressing receptors to immunomodulatory cytokines and the number of membrane‐bound receptors per cell is highlighted by evidence of unidirectional or multidirectional changing of these parameters according to cell subset and health status.
IL-1β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and membrane-bound receptors, respectively. The effectiveness of the cytokine depends not only on the percentage of receptor-positive cells in an immunocompetent subset but also on the density of receptor expression. The objective of this study was to investigate the expression of IL-1β membrane-bound receptors (IL-1R1 and IL-1R2) in terms of the percentage of receptor-positive cells and the number of receptors per cell in different subsets of immune cells in RA patients before and after a course of basic (excluding anticytokine) therapy and in healthy individuals. The resulting data indicate differences in the expression of IL-1β receptors among T cells, B cells, and monocytes in healthy volunteers and in rheumatoid arthritis patients. The importance of determining both the relative percentage of cells expressing receptors to immunomodulatory cytokines and the number of membrane-bound receptors per cell is highlighted by evidence of unidirectional or multidirectional changing of these parameters according to cell subset and health status.
IL-1 β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and membrane-bound receptors, respectively. The effectiveness of the cytokine depends not only on the percentage of receptor-positive cells in an immunocompetent subset but also on the density of receptor expression. The objective of this study was to investigate the expression of IL-1 β membrane-bound receptors (IL-1R1 and IL-1R2) in terms of the percentage of receptor-positive cells and the number of receptors per cell in different subsets of immune cells in RA patients before and after a course of basic (excluding anticytokine) therapy and in healthy individuals. The resulting data indicate differences in the expression of IL-1 β receptors among T cells, B cells, and monocytes in healthy volunteers and in rheumatoid arthritis patients. The importance of determining both the relative percentage of cells expressing receptors to immunomodulatory cytokines and the number of membrane-bound receptors per cell is highlighted by evidence of unidirectional or multidirectional changing of these parameters according to cell subset and health status.
Audience Academic
Author Nadezhda S. Shkaruba
Oksana A. Chumasova
Alina A. Alshevskaya
Julia A. Lopatnikova
Aleksey E. Sizikov
Vladimir A. Kozlov
Sergey V. Sennikov
Aleksander V. Karaulov
AuthorAffiliation 1 Federal State Budgetary Scientific Institution “Research Institute of Fundamental and Clinical Immunology”, Yadrintsevskaya Street 14, Novosibirsk 630099, Russia
2 I.M. Sechenov First Moscow State Medical University of the Ministry of Health, Bolshaya Pirogovskaya Street 2-4, Moscow 119991, Russia
AuthorAffiliation_xml – name: 1 Federal State Budgetary Scientific Institution “Research Institute of Fundamental and Clinical Immunology”, Yadrintsevskaya Street 14, Novosibirsk 630099, Russia
– name: 2 I.M. Sechenov First Moscow State Medical University of the Ministry of Health, Bolshaya Pirogovskaya Street 2-4, Moscow 119991, Russia
Author_xml – sequence: 1
  fullname: Sennikov, Sergey V.
– sequence: 2
  fullname: Karaulov, Aleksander V.
– sequence: 3
  fullname: Sizikov, Aleksey E.
– sequence: 4
  fullname: Chumasova, Oksana A.
– sequence: 5
  fullname: Shkaruba, Nadezhda S.
– sequence: 6
  fullname: Anatolievna, Lopatnikova Julia
– sequence: 7
  fullname: Alshevskaya, Alina A.
– sequence: 8
  fullname: Kozlov, Vladimir A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26448682$$D View this record in MEDLINE/PubMed
BookMark eNqNkt1u0zAYhiM0xLbCEecoEicIlM3_SU6QqjKgUiVQgWPLcT63rhq7sxNgt8WFcE04y5hWiQMUyZ9sP378k_c8O3HeQZY9x-gCY84vCcL8smYVremj7AwzIQpcCXySnaFakKKmHJ9m5zHuEEKcsepJdkpEqqIiZ5l-Z42BAE5DzL3Jl6sC__6Vr0HDofch5lc_DwFitN7lzU2-7LrBee27A_Tg-nwB-33MvwxNhD7m1uXrLQyd6r1t83not8H2Nj7NHhu1j_Dsrs6yb--vvi4-FqtPH5aL-apQgpV9wRvamoaCboCVrDYIG1pXqGmx4LyluFKoMi0zVHCBmGlSh5gWG4JBsRYonWXLydt6tZOHYDsVbqRXVt4O-LCRKvRW70HWJa9JK5rSmPRgBje8wUSTutIVJzXXyfV2ch2GpoNWp8sGtT-SHs84u5Ub_10yXmFe1knw6k4Q_PUAsZedjTo9l3LghyhxSTDlFOERfTmhG5WOZp3xyahHXM4ZpwzVLJVZdvEPKn0tdFanSBibxo8WvJkW6OBjDGDuT4-RHJMjx-TIKTmJfvHwwvfs36gk4PUEbK1r1Q_7fzZICBj1AC5J-n8JWE-AsmNG5M4PwaVwyM9JIxAnJUL0VonJWEpEkUgBro47GCGRGswkS7v-AcSL7MQ
CitedBy_id crossref_primary_10_3389_fped_2020_00129
crossref_primary_10_1016_j_autrev_2020_102617
crossref_primary_10_1016_j_intimp_2024_112400
crossref_primary_10_1016_j_molimm_2016_05_015
crossref_primary_10_1159_000494387
crossref_primary_10_1007_s00109_018_1684_z
crossref_primary_10_15789_1563_0625_2019_2_209_220
crossref_primary_10_1016_j_jtbi_2019_110113
crossref_primary_10_2147_JPR_S408814
crossref_primary_10_1007_s12088_022_01027_8
crossref_primary_10_15789_1563_0625_2019_3_379_396
Cites_doi 10.4049/jimmunol.153.10.4766
10.4049/jimmunol.171.12.6814
10.1111/j.1600-065x.2008.00624.x
10.1152/ajpcell.2001.280.4.C943
10.4049/jimmunol.158.8.3861
10.1038/nrrheum.2010.4
10.1016/j.smim.2013.10.008
10.1006/clin.1994.1100
10.1007/s10616-013-9546-6
10.1126/science.8332913
10.1172/jci26631
10.1093/rheumatology/keu351
10.1016/S0021-9258(19)49611-7
10.1016/s1471-4906(01)01941-x
10.1007/bf03044757
10.1111/j.1600-065x.2008.00701.x
10.1146/annurev.immunol.14.1.397
10.1073/pnas.92.5.1714
10.1086/315315
10.1084/jem.183.4.1841
10.1155/2014/681678
10.1038/nri2094
10.1371/journal.pone.0005293
10.1097/MED.0000000000000103
10.2174/1381612820666140825122247
10.1186/ar4130
10.1128/mcb.01808-08
10.1111/jcmm.12200
10.2332/allergolint.10-RAI-0190
10.1002/eji.200737395
ContentType Journal Article
Copyright Copyright © 2015 Alina A. Alshevskaya et al.
COPYRIGHT 2015 John Wiley & Sons, Inc.
Copyright © 2015 Alina A. Alshevskaya et al. 2015
Copyright_xml – notice: Copyright © 2015 Alina A. Alshevskaya et al.
– notice: COPYRIGHT 2015 John Wiley & Sons, Inc.
– notice: Copyright © 2015 Alina A. Alshevskaya et al. 2015
DBID 188
ADJCN
AHFXO
RHU
RHW
RHX
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1155/2015/948393
DatabaseName 華藝線上圖書館
الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE


MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1466-1861
Editor Voronov, Elena
Editor_xml – sequence: 1
  givenname: Elena
  surname: Voronov
  fullname: Voronov, Elena
EndPage 1014-493
ExternalDocumentID oai_doaj_org_article_97592d6b7ff146f1b5b12c298c85295c
A453409445
10_1155_2015_948393
26448682
1072656
P20160527003_201512_201703060008_201703060008_1006_1014_493
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
188
24P
29M
2UF
2WC
36B
3V.
4.4
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
8G5
AAFWJ
AAJEY
ABDBF
ABUWG
ACGFO
ACIHN
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFPKN
AHMBA
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CEFSP
CNMHZ
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M2O
M48
M7P
M~E
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RHU
RHX
RNS
RPM
SV3
TR2
TUS
UKHRP
UZ5
WOQ
WOW
~8M
ADJCN
AHFXO
CAG
COF
IL9
IPNFZ
OVD
RIG
TEORI
RHW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-a647t-5b3dfb3ecbe4749f01f3980bd1655d318a08fd4f365604fb8fd2fd1f21ea4de33
IEDL.DBID RPM
ISSN 0962-9351
IngestDate Mon Nov 04 19:58:54 EST 2024
Tue Sep 17 21:14:34 EDT 2024
Fri Aug 16 00:49:38 EDT 2024
Wed Oct 16 18:05:49 EDT 2024
Tue Oct 15 04:49:27 EDT 2024
Fri Nov 22 02:41:35 EST 2024
Sat Sep 28 07:57:13 EDT 2024
Sun Jun 02 18:51:52 EDT 2024
Wed Nov 06 05:58:25 EST 2024
Tue Oct 01 22:52:01 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2015
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a647t-5b3dfb3ecbe4749f01f3980bd1655d318a08fd4f365604fb8fd2fd1f21ea4de33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Elena Voronov
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581579/
PMID 26448682
PQID 1721353019
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_97592d6b7ff146f1b5b12c298c85295c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4581579
proquest_miscellaneous_1721353019
gale_infotracmisc_A453409445
gale_infotracacademiconefile_A453409445
crossref_primary_10_1155_2015_948393
pubmed_primary_26448682
hindawi_primary_10_1155_2015_948393
emarefa_primary_1072656
airiti_journals_P20160527003_201512_201703060008_201703060008_1006_1014_493
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: United States
PublicationTitle Mediators of Inflammation
PublicationTitleAlternate Mediators Inflamm
PublicationYear 2015
Publisher Hindawi Limiteds
Hindawi Publishing Corporation
John Wiley & Sons, Inc
Hindawi Limited
Publisher_xml – name: Hindawi Limiteds
– name: Hindawi Publishing Corporation
– name: John Wiley & Sons, Inc
– name: Hindawi Limited
References (6) 2014; 21
(30) 2008; 38
(3) 2015; 54
(31) 2000; 181
(11) 1992; 267
(21) 1994; 5
(28) 2009; 29
(24) 1996; 14
(27) 2014; 18
(33) 1996; 183
(12) 1994; 72
(15) 1995; 92
(20) 2008; 223
(14) 2008; 226
(4) 2015; 21
(22) 1968; 97, article 7
(8) 2010; 6
(23) 2013; 65
(25) 2006; 116
(18) 2003; 171
(29) 2001; 280
(10) 2001; 22
(7) 2013; 25
(32) 1995; 147
(16) 1994; 153
(26) 2007; 7
(1) 1999; 94
(2) 2014; 2014
(5) 2013; 15
(9) 1993; 261
(17) 1997; 158
(13) 2010; 59
(19) 2009; 4
25191854 - Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):461-7
18236400 - Eur J Immunol. 2008 Mar;38(3):750-62
24877127 - Biomed Res Int. 2014;2014:681678
20414049 - Allergol Int. 2010 Jun;59(2):125-35
19161412 - Immunol Rev. 2008 Dec;226:10-8
16410834 - J Clin Invest. 2006 Feb;116(2):414-21
1386364 - J Biol Chem. 1992 Aug 5;267(22):15836-41
7495308 - Am J Pathol. 1995 Dec;147(6):1852-61
5707208 - Scand J Clin Lab Invest Suppl. 1968;97:7
19401759 - PLoS One. 2009;4(4):e5293
25163743 - Curr Pharm Des. 2015;21(2):142-6
24275598 - Semin Immunol. 2013 Dec 15;25(6):469-84
20177398 - Nat Rev Rheumatol. 2010 Apr;6(4):232-41
19564411 - Mol Cell Biol. 2009 Sep;29(17):4778-87
10641509 - Med Klin (Munich). 1999 Dec 15;94(12):673-80
25193807 - Rheumatology (Oxford). 2015 Mar;54(3):545-53
24460759 - J Cell Mol Med. 2014 Mar;18(3):492-502
7878046 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1714-8
11377293 - Trends Immunol. 2001 Jun;22(6):328-36
17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42
14662887 - J Immunol. 2003 Dec 15;171(12):6814-9
9103454 - J Immunol. 1997 Apr 15;158(8):3861-8
7727685 - Eur Cytokine Netw. 1994 Nov-Dec;5(6):517-31
23440375 - Cytotechnology. 2013 Oct;65(5):795-802
8717520 - Annu Rev Immunol. 1996;14:397-440
8020198 - Clin Immunol Immunopathol. 1994 Jul;72(1):9-14
7963543 - J Immunol. 1994 Nov 15;153(10):4766-74
8666940 - J Exp Med. 1996 Apr 1;183(4):1841-50
11245611 - Am J Physiol Cell Physiol. 2001 Apr;280(4):C943-53
10720514 - J Infect Dis. 2000 Mar;181(3):927-32
18613828 - Immunol Rev. 2008 Jun;223:20-38
23374912 - Arthritis Res Ther. 2013;15(1):204
8332913 - Science. 1993 Jul 23;261(5120):472-5
e_1_2_9_30_2
e_1_2_9_10_2
e_1_2_9_33_2
e_1_2_9_12_2
e_1_2_9_31_2
e_1_2_9_11_2
Bossu P. (e_1_2_9_32_2) 1995; 147
e_1_2_9_14_2
e_1_2_9_13_2
e_1_2_9_16_2
e_1_2_9_15_2
e_1_2_9_18_2
e_1_2_9_17_2
e_1_2_9_19_2
e_1_2_9_20_2
e_1_2_9_23_2
e_1_2_9_7_2
e_1_2_9_6_2
e_1_2_9_5_2
e_1_2_9_4_2
e_1_2_9_3_2
e_1_2_9_2_2
e_1_2_9_1_2
e_1_2_9_9_2
e_1_2_9_8_2
Dinarello C. A. (e_1_2_9_21_2) 1994; 5
Böyum A. (e_1_2_9_22_2) 1968; 97
e_1_2_9_25_2
e_1_2_9_24_2
e_1_2_9_27_2
e_1_2_9_26_2
e_1_2_9_29_2
e_1_2_9_28_2
References_xml – volume: 171
  start-page: 6814
  issue: 12
  year: 2003
  end-page: 6819
  ident: 18
  article-title: Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding
  publication-title:
– volume: 65
  start-page: 795
  issue: 5
  year: 2013
  end-page: 802
  ident: 23
  article-title: Optimized flow cytometry protocol for analysis of surface expression of interleukin-1 receptor types I and II
  publication-title:
– volume: 14
  start-page: 397
  year: 1996
  end-page: 440
  ident: 24
  article-title: Role of cytokines in rheumatoid arthritis
  publication-title:
– volume: 226
  start-page: 10
  issue: 1
  year: 2008
  end-page: 18
  ident: 14
  article-title: The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress
  publication-title:
– volume: 267
  start-page: 15836
  issue: 22
  year: 1992
  end-page: 15841
  ident: 11
  article-title: Interleukin 1 induces NF- B through its type I but not its type II receptor in lymphocytes
  publication-title:
– volume: 21
  start-page: 142
  issue: 2
  year: 2015
  end-page: 146
  ident: 4
  article-title: Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment
  publication-title:
– volume: 38
  start-page: 750
  issue: 3
  year: 2008
  end-page: 762
  ident: 30
  article-title: Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes
  publication-title:
– volume: 183
  start-page: 1841
  issue: 4
  year: 1996
  end-page: 1850
  ident: 33
  article-title: Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface ‘receptor’ with anti-interleukin-1 function
  publication-title:
– volume: 72
  start-page: 9
  issue: 1
  year: 1994
  end-page: 14
  ident: 12
  article-title: The two interleukin-1 receptors play different roles in IL-1 actions
  publication-title:
– volume: 116
  start-page: 414
  issue: 2
  year: 2006
  end-page: 421
  ident: 25
  article-title: Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells
  publication-title:
– volume: 147
  start-page: 1852
  issue: 6
  year: 1995
  end-page: 1861
  ident: 32
  article-title: Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1
  publication-title:
– volume: 59
  start-page: 125
  issue: 2
  year: 2010
  end-page: 135
  ident: 13
  article-title: IL-1 and allergy
  publication-title:
– volume: 5
  start-page: 517
  issue: 6
  year: 1994
  end-page: 531
  ident: 21
  article-title: The biological properties of interleukin-1
  publication-title:
– volume: 153
  start-page: 4766
  issue: 10
  year: 1994
  end-page: 4774
  ident: 16
  article-title: Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids
  publication-title:
– volume: 22
  start-page: 328
  issue: 6
  year: 2001
  end-page: 336
  ident: 10
  article-title: Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
  publication-title:
– volume: 92
  start-page: 1714
  issue: 5
  year: 1995
  end-page: 1718
  ident: 15
  article-title: Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 precursor and loses affinity for IL-1 receptor antagonist
  publication-title:
– volume: 54
  start-page: 545
  issue: 3
  year: 2015
  end-page: 553
  ident: 3
  article-title: Bone resorption correlates with the frequency of CD5 B cells in the blood of patients with rheumatoid arthritis
  publication-title:
– volume: 18
  start-page: 492
  issue: 3
  year: 2014
  end-page: 502
  ident: 27
  article-title: Influence of type-I interferon receptor expression level on the response to type-I interferons in human pancreatic cancer cells
  publication-title:
– volume: 4
  issue: 4
  year: 2009
  ident: 19
  article-title: Alternate splicing of interleukin-1 receptor type II (IL1R2) correlates with clinical glucocorticoid responsiveness in patients with AIED
  publication-title:
– volume: 15
  issue: 1, article 204
  year: 2013
  ident: 5
  article-title: Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis
  publication-title:
– volume: 6
  start-page: 232
  issue: 4
  year: 2010
  end-page: 241
  ident: 8
  article-title: IL-1 pathways in inflammation and human diseases
  publication-title:
– volume: 2014
  year: 2014
  end-page: 14
  ident: 2
  article-title: B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers
  publication-title:
– volume: 29
  start-page: 4778
  issue: 17
  year: 2009
  end-page: 4787
  ident: 28
  article-title: Receptor density is key to the alpha2/beta interferon differential activities
  publication-title:
– volume: 223
  start-page: 20
  issue: 1
  year: 2008
  end-page: 38
  ident: 20
  article-title: IL-1, IL-18, and IL-33 families of cytokines
  publication-title:
– volume: 261
  start-page: 472
  issue: 5120
  year: 1993
  end-page: 475
  ident: 9
  article-title: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
  publication-title:
– volume: 181
  start-page: 927
  issue: 3
  year: 2000
  end-page: 932
  ident: 31
  article-title: CD4 T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1
  publication-title:
– volume: 158
  start-page: 3861
  issue: 8
  year: 1997
  end-page: 3868
  ident: 17
  article-title: TNF- , unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells
  publication-title:
– volume: 94
  start-page: 673
  issue: 12
  year: 1999
  end-page: 680
  ident: 1
  article-title: Rheumatoid arthritis: new molecular and cellular aspects
  publication-title:
– volume: 280
  start-page: C943
  issue: 4
  year: 2001
  end-page: C953
  ident: 29
  article-title: Regulation of P2X nucleotide receptor function in human monocytes by extracellular ions and receptor density
  publication-title:
– volume: 25
  start-page: 469
  issue: 6
  year: 2013
  end-page: 484
  ident: 7
  article-title: Treating inflammation by blocking interleukin-1 in humans
  publication-title:
– volume: 7
  start-page: 429
  issue: 6
  year: 2007
  end-page: 442
  ident: 26
  article-title: Cytokines in the pathogenesis of rheumatoid arthritis
  publication-title:
– volume: 97, article 7
  year: 1968
  ident: 22
  article-title: Separation of leukocytes from blood and bone marrow. Introduction
  publication-title:
– volume: 21
  start-page: 461
  issue: 6
  year: 2014
  end-page: 467
  ident: 6
  article-title: T-cells and B-cells in osteoporosis
  publication-title:
– ident: e_1_2_9_16_2
  doi: 10.4049/jimmunol.153.10.4766
– ident: e_1_2_9_18_2
  doi: 10.4049/jimmunol.171.12.6814
– ident: e_1_2_9_20_2
  doi: 10.1111/j.1600-065x.2008.00624.x
– ident: e_1_2_9_29_2
  doi: 10.1152/ajpcell.2001.280.4.C943
– volume: 147
  start-page: 1852
  year: 1995
  ident: e_1_2_9_32_2
  article-title: Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1
  publication-title: The American Journal of Pathology
  contributor:
    fullname: Bossu P.
– ident: e_1_2_9_17_2
  doi: 10.4049/jimmunol.158.8.3861
– ident: e_1_2_9_8_2
  doi: 10.1038/nrrheum.2010.4
– ident: e_1_2_9_7_2
  doi: 10.1016/j.smim.2013.10.008
– ident: e_1_2_9_12_2
  doi: 10.1006/clin.1994.1100
– ident: e_1_2_9_23_2
  doi: 10.1007/s10616-013-9546-6
– ident: e_1_2_9_9_2
  doi: 10.1126/science.8332913
– ident: e_1_2_9_25_2
  doi: 10.1172/jci26631
– ident: e_1_2_9_3_2
  doi: 10.1093/rheumatology/keu351
– ident: e_1_2_9_11_2
  doi: 10.1016/S0021-9258(19)49611-7
– ident: e_1_2_9_10_2
  doi: 10.1016/s1471-4906(01)01941-x
– volume: 97
  year: 1968
  ident: e_1_2_9_22_2
  article-title: Separation of leukocytes from blood and bone marrow. Introduction
  publication-title: Scandinavian Journal of Clinical and Laboratory Investigation, Supplement
  contributor:
    fullname: Böyum A.
– ident: e_1_2_9_1_2
  doi: 10.1007/bf03044757
– ident: e_1_2_9_14_2
  doi: 10.1111/j.1600-065x.2008.00701.x
– volume: 5
  start-page: 517
  year: 1994
  ident: e_1_2_9_21_2
  article-title: The biological properties of interleukin-1
  publication-title: European Cytokine Network
  contributor:
    fullname: Dinarello C. A.
– ident: e_1_2_9_24_2
  doi: 10.1146/annurev.immunol.14.1.397
– ident: e_1_2_9_15_2
  doi: 10.1073/pnas.92.5.1714
– ident: e_1_2_9_31_2
  doi: 10.1086/315315
– ident: e_1_2_9_33_2
  doi: 10.1084/jem.183.4.1841
– ident: e_1_2_9_2_2
  doi: 10.1155/2014/681678
– ident: e_1_2_9_26_2
  doi: 10.1038/nri2094
– ident: e_1_2_9_19_2
  doi: 10.1371/journal.pone.0005293
– ident: e_1_2_9_6_2
  doi: 10.1097/MED.0000000000000103
– ident: e_1_2_9_4_2
  doi: 10.2174/1381612820666140825122247
– ident: e_1_2_9_5_2
  doi: 10.1186/ar4130
– ident: e_1_2_9_28_2
  doi: 10.1128/mcb.01808-08
– ident: e_1_2_9_27_2
  doi: 10.1111/jcmm.12200
– ident: e_1_2_9_13_2
  doi: 10.2332/allergolint.10-RAI-0190
– ident: e_1_2_9_30_2
  doi: 10.1002/eji.200737395
SSID ssj0005448
Score 2.1712084
Snippet IL-1β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and...
IL‐1 β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and...
IL-1 β is involved in the induction and maintenance of chronic inflammation in rheumatoid arthritis (RA). Its activity is regulated and induced by soluble and...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
hindawi
emarefa
airiti
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1006
SubjectTerms Adolescent
Adult
Aged
Arthritis, Rheumatoid - metabolism
B-Lymphocytes - metabolism
Female
Flow Cytometry
Gene expression
Genetic aspects
Health aspects
Humans
Interleukin-1beta - metabolism
Interleukins
Male
Middle Aged
Monocytes - metabolism
Observations
Receptors, Interleukin-1 - metabolism
Rheumatoid arthritis
T-Lymphocytes - metabolism
Young Adult
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagEogL4k1KQUZU4hR1_YrjY2m3asVDiIfEzYpjWxupSip2V5S_xQ_hNzHjeFcNQnDhlDiJnHhenonH3xCyH0KjK9nUpVNalBJXCuvIwRgG6RHu3JuUjHn6Ub_7Uh_PESZnW-oLc8JGeOCRcAdGK8N95XSMoNSROeUYb7mp2xrXqNpkfWfVJpjaJHfIVDcL_HNeGqFY3pkHkydE-0wdGAmOgYBZp-kQO2gyKSXs_rRBt4F2s7XVNxYYJX_r_uSL_p5SeWWOOrlDbmfnkh6Og7pLroX-Hrn5Ni-f3yftcS6HAsaBDpGevSnZzx8UXMdwgVV36Pwy58X21H2nZ7h3ZGizZ72iR-H8fEnR1ITVknY9_bAIa_B4h87jOxcJH-kB-Xwy_3R0WuYqC2VTSb0qlRM-OhFaF6SWJs5YFKaeOc8qpTyofDOro5dRIEyPjA4aPHoWOQuN9EGIh2SnH_rwmFCtXDDMVRBxK9kGZ2qmI_jFKsI5dF6Q1yO9bVaUpX3PEeJO4fK3sMgaxvGAdqhC_2TaYJiFh9WFrTSiIPsbptmLEZrDppBGqdSTHZlckFfI0O0jiKedLoCU2Sxl9l9SVpBHWRyuvEpzIElBXqJ4WLQHwPm2ydsagCKIrGUPpRIYQ0tVkL3Jk6DH7eT2iyxgfx_N843wWewAU-T6MKyXFmN5ocBeG_jYURi3HaUovKp5QfRETCdEmd7pu0UCG5eqZkqb3f9BxSfkFg5l_IO1R3ZWX9fhKbm-9OtnSX1_AYHHPoc
  priority: 102
  providerName: Directory of Open Access Journals
Title Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis
URI https://www.airitilibrary.com/Article/Detail/P20160527003-201512-201703060008-201703060008-1006-1014-493
https://search.emarefa.net/detail/BIM-1072656
https://dx.doi.org/10.1155/2015/948393
https://www.ncbi.nlm.nih.gov/pubmed/26448682
https://search.proquest.com/docview/1721353019
https://pubmed.ncbi.nlm.nih.gov/PMC4581579
https://doaj.org/article/97592d6b7ff146f1b5b12c298c85295c
Volume 2015
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfoBIgXxDeBURkxiaesdWLH8ePoOq0aQxMfEm9WnNhrpS6p1lbAv8Ufwt_EneNUC0I88JS6SRzH9-G7-O53hBxYW8iMF3lshExjjjuFuUtAGVpeIdx5pXww5ukn-eFrfjxFmBzR5cL4oP3SLA7r5dVhvZj72MrVVTnq4sRGF-cTLnImpBoNyABsw85F7-I6uC-ZBaZ5EqtUsJCUB-smOPpMjBQHmwDL53jXJEMEvtvFAhGEekuTR_D3aboFtIudxr4zR1_52-JvFumfgZU3VqqTB-R-MDHpUfsqD8ktWz8id8_DJvpjUh6HoiigImjj6Ox9zH79pGBA2hXW3qHT7yE6tqbmB51hBklTBvt6Qyd2uVxTVDh2s6aLmn6c2y3Yvc2iwmfOPUrSE_LlZPp5chqHWgtxkXG5iYVJK2dSWxrLJVduzFyq8rGpWCZEBYJfjHNXcZciWA93BhqJq5hLmC14ZdP0Kdmrm9o-J1QKYxUzGfjdgpfWqJxJB9axcPAbOo_IWTvfOojLWl8kCHQncBM81UglluABtVGGVkq_wTAWD2sMa67SiBx0RNOrFqBDe8dGCN-TbukdkXdI0N0liKrt_2iuL3XgLa2kUEmVGekcLCAOhmxYUiYqL3PcDy0j8iyww41HyQSmJCJvkT00agWgfFmE5AaYEcTX0kdcpOhJcxGR_d6VIM1l7_SbwGD_fpvXHfNp7AAD5WrbbNcaPfpUgNZWMNiWGXcddQwfEdlj096k9M-ABHrI8SBxL_77zpfkHo6__Xi1T_Y211v7igzW1XYIjszsbOg_hgy9KP8G2OlBhw
link.rule.ids 230,315,729,782,786,866,879,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbYuL5wvwQGBDGJp6x1Ysfx4-g6tVo7TTAk3qw4sWmlLqnWVsDf4ofwmzjHcaoFIR721LpOndj-fHxOfM53CNk3Jhcpy7NIc5FEDE8KMxuDMDSsRLrzUjpnzNFncfo1OxoiTQ5vY2Gc036h5wfV4uKgms-cb-Xyoui1fmK9s-mA8YxyIXs75Cas136_NdJbzw7mkmaBch5HMuHUh-XBzgmmPuU9yUArwAQ6zjhJkYPvVj5HDqHO5uQ4_F2gbg7lfCuzb8_QWv4-_5dO-rdr5ZW96vjBNXv5kNz3yml42FQ_IjdM9Zjcmfrj9yekOPLpVEC4hLUNx5OI_v4Vgupplpi1Jxz-8H61Vah_hmOMPakLr5mvw4FZLFYhiiqzXoXzKvw0MxvQmOt5ifecOX6lp-TL8fB8MIp8loYoT5lYR1wnpdWJKbRhgknbpzaRWV-XNOW8BJGR9zNbMpsgzQ-zGgqxLamNqclZaZLkGdmt6sq8IKHg2kiqU7DYOSuMlhkVFvRqbuE7NB6Qk2aelF9oK3UWI0Uex-PzROHs0hg_UI6lqN90CxS9-DA7sWIyCch-O9lq2VB7KGcSce5aUg1OAvIRgbC9BPm43Q_15Tfl50tJwWVcplpYC1uPhUfWNC5imRUZnqQWAXnuYXTlViKGIQnIB4SVQnkCiClyHxYBI4LMXOqQ8QRtcMYDste5EuRA0al-74H5_968a0GrsAF0satMvVkpfBeQcJD3Eh62AfG2oXahBER04N0ZlG4NoNqRlXsUv7z2P9-Su6Pz6URNxqcnr8g97EvzCmyP7K4vN-Y12VmVmzdOBPwB6ehVKA
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYBVZceC4QWCCIlThlW8d2Eh-XPrTVPlTxkLhZcWLTSN2k2rYC_hY_hN_EjOtUG4Q4wClx4jix_Xk8E4-_IeTQmDxNeJ5FWqQs4rhSmNkYhKHhJdKdl9I5Y558SC8-Z8MR0uRsQ305p_1CV0f1_PKormbOt3JxWfRaP7He9HzARUZFKnuL0vZ2yE0Ys_24NdRb7w7uAmeBgh5Hkgnqt-bB7AnmPhU9yUEzwCA6zkBJkIfvVl4hj1BngnI8_m6zbg7pfCu3b8_QYv5a_Ukv_d298tp8Nb73HzW9T-56JTU83mR5QG6Y-iHZO_fL8I9IMfRhVUDIhI0NJ2cR_fkjBBXULDB6Tzj65v1r61B_Dye4B6UpvIa-CgdmPl-GKLLMahlWdfh-ZtagOTdVie-cOZ6lffJpPPo4OIl8tIYoT3i6ioRmpdXMFNrwlEvbp5bJrK9LmghRgujI-5ktuWVI98OthkRsS2pjanJeGsYek926qc1TEqZCG0l1Apa74IXRMqOpBf1aWDiHwgNyuukr5QfcUk1jpMoTuIzOFPYwjfGA8ixBPaeboOjNh1GKFZcsIIdth6vFhuJDOdNICFeS2mAlIO8QDNssyMvtLjRXX5TvMyVTIeMy0am1MAVZ-GRN4yKWWZHhimoRkCceStdelcbQJAF5i9BSKFcANUXut0dAiyBDlzrmgqEtzkVADjo5QR4UndtvPDj_XpvXLXAVFoCudrVp1kuF_wSYALkv4WM3QN4W1A6WgKQdiHcapXsHkO1Iyz2Sn_3zk6_I3nQ4VmeTi9Pn5A5WZfMn7IDsrq7W5gXZWZbrl04K_ALO7Veo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+of+IL-1%CE%B2+Receptors+Expression+by+Immunocompetent+Cells+Subsets+in+Rheumatoid+Arthritis&rft.jtitle=Mediators+of+inflammation&rft.au=Alshevskaya%2C+Alina+A&rft.au=Lopatnikova%2C+Julia+A&rft.au=Shkaruba%2C+Nadezhda+S&rft.au=Chumasova%2C+Oksana+A&rft.date=2015-01-01&rft.eissn=1466-1861&rft.volume=2015&rft.spage=948393&rft.epage=948393&rft_id=info:doi/10.1155%2F2015%2F948393&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon